We are live on ! Find out more
LRCX icon

Lam Research

2,107 hedge funds and large institutions have $136B invested in Lam Research in 2025 Q3 according to their latest regulatory filings, with 351 funds opening new positions, 765 increasing their positions, 729 reducing their positions, and 93 closing their positions.

New
Increased
Maintained
Reduced
Closed

277% more first-time investments, than exits

New positions opened: 351 | Existing positions closed: 93

67% more funds holding in top 10

Funds holding in top 10: 4982 (+33)

33% more capital invested

Capital invested by funds: $103B → $136B (+$33.7B)

12% more funds holding

Funds holding: 1,8782,107 (+229)

5% more repeat investments, than reductions

Existing positions increased: 765 | Existing positions reduced: 729

1.76% less ownership

Funds ownership: 82.54%80.78% (-1.8%)

16% less call options, than puts

Call options by funds: $2.73B | Put options by funds: $3.24B

Holders
2,107
Holders Change
+229
Holders Change %
+12.19%
% of All Funds
27.65%
Holding in Top 10
82
Holding in Top 10 Change
+33
Holding in Top 10 Change %
+67.35%
% of All Funds
1.08%
New
351
Increased
765
Reduced
729
Closed
93
Calls
$2.73B
Puts
$3.24B
Net Calls
-$506M
Net Calls Change
-$323M
Name Holding Trade Value Shares
Change
Change in
Stake
OGC
876
Oak Grove Capital
New Hampshire
$2.45M -$275K -2,600 -12%
FGA
877
Fortis Group Advisors
New Jersey
$2.45M -$27.5K -260 -2%
LA
878
Lindenwold Advisors
Pennsylvania
$2.44M -$368K -3,478 -16%
SFCL
879
Strengthening Families & Communities LLC
Massachusetts
$2.43M +$1.81M +17,091 +3,189%
TAM
880
Tocqueville Asset Management
New York
$2.43M -$26K -246 -1%
IFU
881
iSAM Funds (UK)
United Kingdom
$2.42M +$1.92M +18,094 New
SF
882
Summit Financial
New Jersey
$2.42M +$1.08M +10,174 +129%
OCPWS
883
One Charles Private Wealth Services
Massachusetts
$2.4M +$6.04K +57 +0.3%
AT
884
AMF Tjänstepension
Sweden
$2.4M +$1.9M +17,916 New
EH
885
Equitable Holdings
New York
$2.4M +$30.2K +285 +2%
BAM
886
Belpointe Asset Management
Nevada
$2.4M +$12K +113 +0.6%
Fayez Sarofim & Co
887
Fayez Sarofim & Co
Texas
$2.39M +$3.07K +29 +0.2%
BTI
888
Blue Trust Inc
Georgia
$2.39M -$708K -6,689 -27%
SWM
889
Shelton Wealth Management
Texas
$2.38M -$98.5K -930 -5%
CP
890
CenterBook Partners
Connecticut
$2.36M +$1.87M +17,649 New
MYLI
891
Meiji Yasuda Life Insurance
Japan
$2.36M -$168K -1,586 -8%
SL
892
Salomon & Ludwin
Virginia
$2.35M +$35.7K +337 +2%
SAM
893
Shell Asset Management
Netherlands
$2.35M -$5.52M -52,179 -75%
AWCI
894
Alpine Woods Capital Investors
New York
$2.34M +$69.9K +660 +4%
CFG
895
Citizens Financial Group
Rhode Island
$2.34M +$211K +1,993 +13%
TSWM
896
Triangle Securities Wealth Management
North Carolina
$2.34M -$14.3K -135 -0.8%
BCM
897
Brookstone Capital Management
Illinois
$2.33M +$158K +1,492 +9%
Kayne Anderson Rudnick Investment Management
898
Kayne Anderson Rudnick Investment Management
California
$2.33M -$35.3K -333 -2%
LAM
899
L2 Asset Management
Massachusetts
$2.33M -$290K -2,739 -14%
TWM
900
Tradition Wealth Management
Minnesota
$2.31M -$49.7K -469 -3%

LRCX Hedge Fund Activity: Q3 2025 in Review

2,107 of the 7,620 institutional investors tracked by Wall St. Rank reported a position in Lam Research (LRCX) for Q3 2025, worth a combined $136B — up 33% from $103B a quarter earlier.

Buyers outnumbered sellers: 351 funds opened new LRCX positions and 93 closed out — a net gain of 258 holders — while 765 added to existing stakes and 729 trimmed.

The largest buyer was Arrowstreet Capital, adding an estimated $1.06B. The largest seller was JP Morgan Chase, cutting an estimated $1.13B.

  • 2,107 institutional investors held Lam Research (LRCX) as of Q3 2025, up from 1,878 in Q2 2025.
  • Funds reported $136B of Lam Research stock for Q3 2025, up 33% quarter-over-quarter.
  • 351 funds opened new Lam Research positions in Q3 2025 and 93 closed out, a net change of +258 holders.
  • The largest Lam Research buyer in Q3 2025 was Arrowstreet Capital, an estimated $1.06B added.
  • The largest Lam Research seller in Q3 2025 was JP Morgan Chase, an estimated $1.13B sold.

Based on aggregated 13F filings for Q3 2025.